Multilevel Analysis of MYC and BCL2 Aberrations in Diffuse Large B‐Cell Lymphoma: Identifying a High‐Risk Patient Subgroup Across Cell‐of‐Origin Using Targeted Sequencing.

MLA

Vimalathas, Gayaththri, et al. “Multilevel Analysis of MYC and BCL2 Aberrations in Diffuse Large B‐Cell Lymphoma: Identifying a High‐Risk Patient Subgroup Across Cell‐of‐Origin Using Targeted Sequencing.” European Journal of Haematology, Nov. 2024, p. 1. EBSCOhost, https://doi.org/10.1111/ejh.14345.

APA

Vimalathas, G., Lang, C. S., Green, T. M., Møller, M. B., Nyvold, C. G., Hansen, M. H., & Larsen, T. S. (2024). Multilevel Analysis of MYC and BCL2 Aberrations in Diffuse Large B‐Cell Lymphoma: Identifying a High‐Risk Patient Subgroup Across Cell‐of‐Origin Using Targeted Sequencing. European Journal of Haematology, 1. https://doi.org/10.1111/ejh.14345

Chicago

Vimalathas, Gayaththri, Cecilie Steensboe Lang, Tina Marie Green, Michael Boe Møller, Charlotte Guldborg Nyvold, Marcus Høy Hansen, and Thomas Stauffer Larsen. 2024. “Multilevel Analysis of MYC and BCL2 Aberrations in Diffuse Large B‐Cell Lymphoma: Identifying a High‐Risk Patient Subgroup Across Cell‐of‐Origin Using Targeted Sequencing.” European Journal of Haematology, November, 1. doi:10.1111/ejh.14345.